Inherited disorders of iron metabolism
暂无分享,去创建一个
[1] Y. P. Goldberg. Juvenile Hereditary Hemochromatosis , 2011 .
[2] M. Gobbi,et al. TFR2-Related Hereditary Hemochromatosis , 2011 .
[3] P. Malfertheiner,et al. A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis , 2010, Hepatology.
[4] D. Gertig,et al. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 μg/L are at low risk of hemochromatosis , 2010, Hepatology.
[5] M. Muckenthaler,et al. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA , 2010, The Biochemical journal.
[6] L. Silvestri,et al. Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient mice. , 2010, Blood.
[7] A. Pietrangelo. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. , 2010, Gastroenterology.
[8] C. Beaumont,et al. Hepcidin levels in hereditary hyperferritinemia: Insights into the iron-sensing mechanism in hepatocytes. , 2010, World journal of gastroenterology.
[9] J. Barton,et al. How I treat hemochromatosis. , 2010, Blood.
[10] Matthias W. Hentze,et al. Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.
[11] Y. Ginzburg,et al. Crosstalk between Iron Metabolism and Erythropoiesis , 2010, Advances in hematology.
[12] N. Andrews,et al. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. , 2010, Blood.
[13] J. Tisdale,et al. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. , 2010, The Journal of clinical investigation.
[14] D. Girelli,et al. Novel TMPRSS6 mutations associated with iron‐refractory iron deficiency anemia (IRIDA) , 2010, Human mutation.
[15] Mario Amendola,et al. Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy , 2010, Neurobiology of Disease.
[16] Toshiko Tanaka,et al. A genome-wide association analysis of serum iron concentrations. , 2010, Blood.
[17] E. Nemeth. Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias , 2009, Advances in hematology.
[18] D. Swinkels,et al. Haematologic data, iron parameters and molecular findings in two new cases of iron‐refractory iron deficiency anaemia , 2009, European journal of haematology.
[19] C. Camaschella,et al. Rare Types of Genetic Hemochromatosis , 2009, Acta Haematologica.
[20] Ian H. Frazer,et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume , 2009, Nature Genetics.
[21] Christian Gieger,et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.
[22] V. Quesada,et al. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. , 2009, Human molecular genetics.
[23] K. Finberg. Iron-refractory iron deficiency anemia. , 2009, Seminars in hematology.
[24] M. Fleming,et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia , 2009, Nature Genetics.
[25] C. Beaumont,et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. , 2009, Blood.
[26] T. Rouault,et al. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. , 2009, Cell metabolism.
[27] C. Peyssonnaux,et al. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. , 2009, The Journal of clinical investigation.
[28] C. Camaschella. BMP6 orchestrates iron metabolism , 2009, Nature Genetics.
[29] C. Beaumont,et al. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis , 2009, Haematologica.
[30] L. Silvestri,et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.
[31] D. Girelli,et al. Immunoassay for human serum hepcidin. , 2008, Blood.
[32] M. Cazzola,et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron , 2008, Haematologica.
[33] C. López-Otín,et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. , 2008, Blood.
[34] C. Beaumont,et al. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. , 2008, Blood.
[35] B. Beutler,et al. The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency , 2008, Science.
[36] N. Andrews,et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.
[37] J. Abkowitz,et al. A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis , 2008, Science.
[38] D. English,et al. Iron-overload-related disease in HFE hereditary hemochromatosis. , 2008, The New England journal of medicine.
[39] D. Reboussin,et al. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study , 2007, American journal of hematology.
[40] T. Ganz,et al. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia , 2007, Haematologica.
[41] A. Iolascon,et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. , 2007, Blood.
[42] Nathalie Boddaert,et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. , 2007, Blood.
[43] W. Sundquist,et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. , 2007, Molecular biology of the cell.
[44] B. Paw,et al. Deficiency of glutaredoxin 5 reveals Fe–S clusters are required for vertebrate haem synthesis , 2005, Nature.
[45] E. Thomson,et al. Hemochromatosis and iron-overload screening in a racially diverse population. , 2005, The New England journal of medicine.
[46] L. Goodnough,et al. Anemia of chronic disease. , 2005, The New England journal of medicine.
[47] Jerry Kaplan,et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.
[48] Sheryl E. Koch,et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy , 2003, Nature Medicine.
[49] G. Práctica,et al. European Association for the Study of the Liver , 1971 .
[50] Jia Ji-don. EASL clinical practice guidelines for HFE hemochromatosis. , 2010, Journal of hepatology.
[51] C. Beaumont,et al. Natural history of recessive inheritance of DMT1 mutations. , 2008, The Journal of pediatrics.